Evidence for proangiogenic cellular and humoral systemic response in patients with acute onset of spinal cord injury

J Spinal Cord Med. 2015 Nov;38(6):729-44. doi: 10.1179/2045772314Y.0000000227. Epub 2014 Jun 26.

Abstract

Context/objective: Traumatic spinal cord injury (SCI) leads to disruption of local vasculature inducing secondary damage of neural tissue. Circulating endothelial progenitor cells (EPCs) play an important role in post-injury regeneration of vasculature, whereas endothelial cells (ECs) reflect endothelial damage.

Methods: Twenty patients with SCI were assessed during the first 24 hours, at day 3, and day 7 post-injury and compared to 25 healthy subjects. We herein investigated EPC and EC counts by flow cytometry as well as the levels of soluble factors (SDF-1, HGF, VEGF, Ang2, EGF, endoglin, PLGF, FGF-2, ET-1, BDNF, IGF-1) regulating their migration and proangiogenic function. To better characterize peripheral blood (PB) cells, global gene expression profiles of PB-derived cells were determined using genome-wide RNA microarray technology.

Results: We found significantly higher EPC (CD34(+)/CD133(+)/VEGFR2(+)) as well as EC (VEGFR2(+)) count in PB of patients with SCI within 7 days post-injury and the increased HGF, ET-1, Ang2, EGF, and PLGF plasma levels. Global gene expression analysis revealed considerably lower expression of genes associated with both innate and adaptive immune response in PB cells in patients.

Conclusion: Collectively, our findings demonstrate that SCI triggers bone marrow-derived EPC mobilization accompanied by increased circulating EC numbers. Significant changes in both chemoattractive and proangiogenic cytokines plasma levels occurring rapidly after SCI suggest their role in SCI-related regenerative responses to injury. Broadened knowledge concerning the mechanisms governing of human organism response to the SCI might be helpful in developing effective therapeutic strategies.

Keywords: Angiogenic factors; Endothelial cells; Endothelial progenitor cells; Immune response; Spinal cord injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AC133 Antigen
  • Adolescent
  • Adult
  • Aged
  • Angiogenic Proteins / blood*
  • Angiogenic Proteins / genetics
  • Angiogenic Proteins / metabolism
  • Antigens, CD / genetics
  • Antigens, CD / metabolism
  • Antigens, CD34 / genetics
  • Antigens, CD34 / metabolism
  • Case-Control Studies
  • Chemokine CXCL12 / genetics
  • Chemokine CXCL12 / metabolism
  • Endothelial Progenitor Cells / metabolism*
  • Female
  • Glycoproteins / genetics
  • Glycoproteins / metabolism
  • Humans
  • Male
  • Middle Aged
  • Peptides / genetics
  • Peptides / metabolism
  • Spinal Cord Injuries / blood*
  • Spinal Cord Injuries / metabolism
  • Vascular Endothelial Growth Factor Receptor-2 / genetics
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism

Substances

  • AC133 Antigen
  • Angiogenic Proteins
  • Antigens, CD
  • Antigens, CD34
  • CXCL12 protein, human
  • Chemokine CXCL12
  • Glycoproteins
  • PROM1 protein, human
  • Peptides
  • KDR protein, human
  • Vascular Endothelial Growth Factor Receptor-2